The Oncology Institute to Participate in B. Riley Securities Institutional Investor Conference
Rhea-AI Summary
The Oncology Institute (NASDAQ:TOI) announced that CEO Dr. Daniel Virnich and CFO Rob Carter will participate in the B. Riley Securities Institutional Investor Conference in Marina Del Rey, CA, on May 21, 2026.
A fireside chat is scheduled from 9:00–9:40 a.m. PT and will be available via webcast on the company’s investor relations website.
Positive
- None.
Negative
- None.
News Market Reaction – TOI
In the May 13 session, TOI gained 1.49%, reflecting a mild positive market reaction. Our momentum scanner triggered 3 alerts that day, indicating moderate trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| May 07 | Q1 2026 earnings | Positive | -1.7% | Strong revenue growth and narrowed net loss for Q1 2026. |
| Apr 27 | Earnings call notice | Neutral | +2.5% | Announced Q1 2026 earnings release date and conference call details. |
| Apr 13 | Medicare savings update | Positive | +7.1% | Reported $1.8M Medicare savings and improved per-episode performance. |
| Apr 09 | Conference participation | Neutral | +0.3% | Announced participation in Needham Healthcare Conference with a fireside chat. |
| Apr 06 | Leadership appointment | Positive | +2.9% | Named a new Chief Legal Officer to oversee legal and compliance functions. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Over the last five announcements, TOI generally saw aligned reactions, including positive moves on operational and leadership news, with a single divergence where strong Q1 2026 results coincided with a modest share price decline.
This announcement follows several months of active newsflow for TOI. On May 7, 2026, the company reported Q1 2026 revenue of $147.4 million, up 41.2% year-over-year, and a narrowed net loss of $2.5 million, though shares fell 1.72%. Earlier in April, TOI highlighted $1.8 million in Medicare savings under the CMS Enhancing Oncology Model and announced participation in the Needham Healthcare Conference and a new Chief Legal Officer, with mostly positive price reactions. Today’s B. Riley conference participation is consistent with that ongoing investor outreach.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CERRITOS, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that Dr. Daniel Virnich, Chief Executive Officer, and Rob Carter, Chief Financial Officer, will participate in the B. Riley Securities Institutional Investor Conference, being held in Marina Del Rey, CA on Thursday, May 21, 2026, including a fireside chat from 9:00–9:40 a.m. PT.
A webcast link of the presentation will be accessible through the Investor Relations section of the Company’s website at https://investors.theoncologyinstitute.com/.
____________________________
About The Oncology Institute (www.theoncologyinstitute.com):
Founded in 2007, The Oncology Institute (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.9 million patients, including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With over 180 employed and affiliate clinicians and over 100 clinics and affiliate locations of care across five states and growing, TOI is changing oncology for the better.
Media
The Oncology Institute, Inc.
marketing@theoncologyinstitute.com
Investors
ICR Healthcare
TOI@icrhealthcare.com
